Unicycive Therapeutics, Inc.
UNCY
$6.80
$0.8614.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 0.00 | 0.00 | 0.00 |
| SG&A Expenses | 15.53M | 12.10M | 10.21M | 9.57M | 9.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.90M | 32.12M | 29.17M | 28.86M | 25.78M |
| Operating Income | -30.90M | -32.12M | -29.17M | -28.86M | -25.78M |
| Income Before Tax | -15.20M | -36.73M | -23.00M | -23.24M | -36.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.20 | -36.73 | -23.00 | -23.24 | -36.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.20M | -36.73M | -23.00M | -23.24M | -36.93M |
| EBIT | -30.90M | -32.12M | -29.17M | -28.86M | -25.78M |
| EBITDA | -30.88M | -32.10M | -29.15M | -28.84M | -25.76M |
| EPS Basic | -1.65 | -7.76 | -7.96 | -8.85 | -12.57 |
| Normalized Basic EPS | 0.09 | -3.69 | -3.81 | -4.36 | -7.56 |
| EPS Diluted | -4.46 | -10.06 | -10.26 | -11.15 | -12.60 |
| Normalized Diluted EPS | -0.88 | -4.66 | -4.78 | -5.33 | -7.56 |
| Average Basic Shares Outstanding | 34.94M | 26.75M | 19.66M | 14.03M | 11.76M |
| Average Diluted Shares Outstanding | 41.26M | 32.36M | 25.28M | 19.65M | 11.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -7.21% | -2.98% | -4.76% | -4.71% | -- |